So much has been written and talked about penicillin, that I feel I am in serious danger of becoming like some other Australian birds-they sing perfectly a short series of notes, but repeat them so often that they become rather boring. So today I thought it might be more interesting to put before you an account of some of the work on the use in medicine of naturally occurring antibacterial substances. There are still many misapprehensions on this subject, and it is one of the fields in which some historical information is of help in the orientation of one's ideas at the present time.
The use of the products of moulds for therapeutic purposes goes back to primitive medicine; there is good evidence that green moulds were especially cultivated in Central Europe for application to wounds, and there is also some evidence that the Mayans in Yucatan cultivated a mould that was called cuxum which was used in medicine, though undoubtedly the Mexicans go too far in claiming that the Mayans discovered penicillin. I have also come across the use of one of the field fungi, a sort of puffball, which was used by one of the Indian tribes in Brazil.
It was as long ago as 1852 that the first record of the use of a micro-organism appeared in The Lancet-from a British general practitioner named Mosse.2" He proposed to use yeast as a treatment for furunculosis. I need hardly say that it is still a popular treatment among some, although yeast has never been clearly shown to produce an antibacterial substance, and if there is any therapeutic benefit from its use, it is probably attributable to something else, possibly the vitamin content.
In 1877 Pasteur and Joubert wrote the following, based on some of their experiments:32
Neutral or slightly alkaline urine is an excellent medium for the bacteria. If the urine is sterile and the culture pure the bacteria multiply so fast that in the course of a few hours their filaments fill the fluid with a downy felt.
* Woodward Lecture. Delivered at Yale University, New Haven, Connecticut, 17 September, 1946. But if when the urine is inoculated with these bacteria an aerobic organism, for example one of the "common bacteria," is sown at the same time, the anthrax bacterium makes little or no growth and sooner or later dies out altogether. It is a remarkable thing that the same phenomenon is seen in the body even of those animals most susceptible to anthrax, leading to the astonishing result that anthrax bacteria can be introduced in profusion into an animal, which yet does not develop the disease; it is only necessary to add some "common 'bacteria" at the same time to the liquid containing the suspension of anthrax bacteria. These facts perhaps justify the highest hopes for therapeutics. This method was illustrated in a figure (Fig. 2) in a paper by Frost, an American, written in 1904,16 about which I shall have more to say later.
The first photographic record of antibiosis was published in Kiel in 1 889 by Doehle9 (Fig. 1) . It showed that anthrax bacilli which had been sown throughout the solid medium in a Petri dish had been inhibited by an organism called Micrococcus anthracotoxicus which had been planted on ithe surface in the form of a square. Thus, by 1889, the phenomenon of microbial antagonism was well known and had been illustrated, and its causation was attributed to the elaboration of chemical substances. Many of the workers had had in mind the use olf this bacterial antagonism for therapeutic purposes.
Another line of reasoning was based on the clinical observation that certain chronic diseases sometimes improved strikingly after an attack of erysipelas, and indeed, in 1883, Fehleisen'4 had treated a case of lupus by injecting srtreptococci from a patient with erysipelas. Emmerich" in 1887 did experimental work along tihese lines and showed ithat it was possible to protect rabbits from dying of anthrax by the simultaneous injection of a streptococcus from a case of erysipelas.
It was the pursuit of this form of experiment which led to the first use of a bacterial product in medicine. In There is no question 'that the work on pyocyanase was the first serious attempt to introduce an antibiotic into medicine. Practically all the ideas and the type of trials which have been conducted wi'th penicillin were undertaken by the workers with pyocyanase. Unfortunately their technique was not so good as that in use at present and they were working with a substance which had marked toxic properties.
While this work on pyocyanase was being actively pursued, other interesting studies on antibiosis were recorded; for example, in 1903, Lode described his experiments24 performed with an accidental bacterial contaminant. He was preparing an agar plate to demonstrate to his class the growth of Micrococcus tetragenus. There was a contamination by an air bacterium, and he noted inhibition of growth around this organism. He subcultured it and observed an inhibitory effect. The bacterium produced a diffusible substance which strongly inhibited the growth of anthrax bacilli and Staph. We have up to the present been concerned with the products of bacteria, but as long ago as 1917 Greig-Smith2' in Australia made the first clear-cut observation on the antagonistic effects of actinomycetes towards certain bacteria. In 1924 Gratia and Dath20 discovered an actinomycete which had the power of dissolving certain pathogenic organisms, and subsequently they performed many experiments on this and other antibiotic organisms. They used a particular actinomycete to dissolve certain pathogenic organisms such as staphylococci for the production of vaccines which they called mycolysates. This, as you will realize, was an idea similar to that proposed by Nicolle using the B. subtilis. It is not an example of the direct use of substances produced by micro-organisms for the treatment of infection, but rather substances are employed to obtain a product suitable for immunization. Actually, these mycolysates, although used fairly extensively in Belgium, have never come into general use in medicine. Much27 and Kimmelstiel,23 about the same time, proposed to use a strain of B. mycoides for the same purpose, and put dissolved organisms for vaccination purposes on the market under the name of "sentocym."
We will now consider the products produced by fungi or moulds. It was in 1896 that Gosio 18 an Italian, described the production of a crystalline substance from a Penicillium which was being investigated as a possible cause of pellagra. This substance, which is now known as mycophenolic acid, was shown by Gosio to inhibit the growth of anthrax bacilli. But no animal experiments were done, owing to the minute amounts of the substance available. Similar observations were made in the United States by Alsberg and Black in 1912,1 who isolated from another Penicillium a substance which they called penicillic acid, not to be confused with penicillin. This, they found, would stop the growth of Bact. coli, but they also noted that the substance was very toxic to animals.
The first instance of the use of fungal products for the treatment of disease is probably the work of Vaudremer, who in 1913 reported39 on the treatment of tuberculosis in animals with the products of Aspergillus fumigatus. He went on to use filtrates from the growth of A. fumigatus for intravenous injections into man. More than 200 cases were treated, from which he concluded that the material used was innocuous, since it did not provoke any febrile reactions. He was not sure, however, that any thera-peutic effect had been produced. It was evident that Vaudremer was trying to obtain a direct lethal effect on the tubercle bacillus by injecting intravenously the metabolic products of Aspergillus fumigatus.
It would be a mistake to believe that all the observations on bacterial and fungal antagonisms were made by those interested in medicine-quite the contrary. It is impossible for me today to consider in any detail the great volume of work contributed by workers in the botanical field and I shall have to be content with mentioning only a few observati,ons. Very clear descriptions, for example, of 'the inhibition of the growth of certain fungi by a bacterium were given by Reinhardt in 1893,36 and he also described inhibitions produced by Penicillia and Aspergilli. An illustration in the work of Harder, published in 1912, shows the inhibition of Stereum purpureunm by Penicillium lutetrn, and again an illustration in Porter's work, published in 1924,33 is of particular interest, for it shows colonies of a Penicillium inhibiting the growth of Pestalozzia, whereas growing on the surface of Pestalozzia are other colonies of a Penicillium which have no inhibitory effects.
The most famous inhibition of this nature, of course, was that described by Fleming in 1929. '5 He observed that an accidental contaminant, subsequently identified as Penicillium notatum, produced lysis of colonies of staphylococcus growing on a plate. He subcultured this mould and found -that it conferred powerful antibacterial powers to the broth on which it had grown. He called the broth in which this antibacterial' substance had been secreted "penicillin," and later the antibacterial substance itself was given this name. He observed that it acted on many important pathogenic organisms, such as the streptococcus and staphylococcus, while others, such as H. influenzae and the Salmonellas, remained unaffected.
The crude metabolism liquid was shown to 'be no more toxic to animals than broth in which nothing had grown. No curative experiments were performed on experimental infection in animals, but the suggesti'on was made that the substance would be useful for dressing septic lesions in man, and indeed some were so treated without, however, any very striking results. The clinical possibilities of this antibiotic were not pursued until the beginning of the next decade, although Fleming maintained his strain of the mould and made use of the broth in differential culture media in the laboratory.
One of the most interesting series of experiments on fungal antagonists was done by Weindling, who noticed that 'Trichoderma ligiorun produced a lethal principle which inhibited the growth of Rhizoctonia solani. Subsequently in 1936 Weindling and Emerson succeeded in isolating this substance, now known as "gliotoxin," in crystalline form. Its properties were examined in considerable detail by many investigators and it has proved to be quite unsuitable for any general chemotherapeutic purpose, but as it affects certain fungi pathogenic to man it may be of use for skin diseases. It is, however, the first good example of a work being carried through from the initial detection of an antagonism to the isolation in crystalline form of the antagonist, with subsequent examination of this product.
In the 1920's a new idea, which has yet to be developed, was introduced by Schiller.37 He brought forward evidence that yeasts and possibly other organisms could be trained to produce substances that were antagonistic to certain bacteria by growing them on media in which the only source of nitrogen was the bodies of the bacteria it was desired to antagonize. He claimed that in such experiments yeasts developed a thermolabile inhibitory substance which might be of value in therapeutics. He called the phenomenon "induced" antagonism, in contradistinction to the "neutral" antagonisms. This interesting idea has as yet received no real confirmation, in fact, some authors do not believe it is valid, but it nevertheless seems to be worth a careful re-examination.
At this juncture I should like to call your attention to the fact that a good deal of progress in the antibiotic field depends on the development of adequate techniques. We are apt to think perhaps that all these techniques are of great origin, but an excellent paper, previously mentioned, published by Frost"6 in 1904, contained a description of seven methods, some of which are employed to this day. One of the more interesting involves the suspensi-on of broth in a collodion sac inside a flask containing more broth. He planted organisms in the broth in the flask and observed whether diffusible inhibitory substances were produced which passed through the collodion and stopped the growth of sensiltive organisms in the sac.
Frost's paper deserves study by those particularly interested in the subject of antibiosis.
The suggestions and experiments on the use of micro-organisms for therapeut7ic purposes up to 1939 may be summarized as follows:
1. The replacement of a pathogenic organism by another and less harmful organism-for example, "Bact. termo" to replace the 'tubercle bacillus in the lungs; staphylococci to replace diphtheria bacilli, pneumococci to replace meningococci in the throat, and lactic acid bacilli and Bact. coli to replace organisms infecting the intestine.
2. Artificial immunization by one organism to protect against infection by another.
3. The use of lytic substances from one organism for the preparation of soluble vaccines of other species-for example, Much's sentocym and Gratia's mycolysates.
4. The use of soluble bacterial or mould products by parenteral injection to treat established diseases-for example, pyocyanase in anthrax, and Vaudremer's extracts of Aspergillus fumigatus and Rappin's extracts of B. subtilis in tuberculosis. These were examples of true chemotherapeutic use.
5. The use of soluble bacterial or mould products as a topical application for the treatment of local infections-for example, pyocyanase and penicillin broth.
In 1939 Dubosl°published his first important paper on a substance isolated from a spore-forming organism, B. brevis. This substance which is now known as "tyrothricin" subsequently received very extensive investigation both from a bacteriological and from a chemotherapeutic angle. Although tyrothrycin was shown to be an effective product for application locally to infected wounds, its great toxicity precluded its use for generalized infections. Nevertheless, this work of Dubos and his associates marked a new level in the investigation of antibiotics for therapeutic purposes.
Shortly after, in 1940, the first paper recording the discovery of the chemotherapeutic properties of penicillin was published from Oxford.' These observations clearly distinguished penicillin from any antibiotic previously described. The Oxford work showed, after a long series of experiments, both chemical and biological, that artificial infections in mice with streptococcus, staphylococcus, and Cl. septique could be completely controlled by the subcutaneous injection of a penicillin extract, so that there was almost 100 per cent survival from infections which otherwise would certainly have been fatal. In other words, penicillin was a chemotherapeutic drug of great power, that is to say, it was of such low toxicity that it could, without producing any toxic signs, be injected by parenteral routes in amounts which would stop the growth of bacteria in all parts of the body. Based on these experimental results on animals penicillin was carried to the clinic with, as you are all aware, some very satisfactory results. The point I wish to emphasize is that the discovery that one of the antibiotics was a real chemotherapeutic agent with some very remarkable and almost miraculous properties was the starting point for investigations in almost every country in the world in a search for other chemotherapeutic agentts.
We now have records of the existence of many hundreds of substances of potential interest. Those extracted from fungi have almost without exception proved to be extremely toxic. Many species of both Penicillia and Aspergilli are known to produce penicillin-like substances, which perhaps are identical with some of the already known penicillins. There is a group of moulds which produce antibacterial substances of a phenolic type, for example, mycophenolic acid from Penicillium brevi compactum, citrinin from Penicillium citrinum, and penicillic acid from Pencillium cyclopium. Although the inhibitions produced by some moulds appear to be very similar under the microscope they are due to chemically distinct substances. The work of isolating and examining these substances proceeds, but I will not weary you with a long list of these very toxic products. Other than penicillin, only one mould product whose properties bring it within the realm of being considered a chemotherapeutic agent has so far been discovered-thait is helvolic acid produced from Aspergillus fumigatus mut. Ielvola. It is a crystalline substance composed only of carbon, hydrogen, and oxygen. It is stable to boiling at pH 2, the free acid is insoluble, though the sodium salt is readily soluble. It has relatively low acute toxicity but continued doses produce fatty degeneration of the liver. Nevertheless, it has been possible to afford a certain degree of protedtion in mice infected with streptococci or staphylococci. It is, however, unlikely to be used in medicine for a number of reasons which I have not the time to develop.
Aside from the great number of Penicillia and Aspergilli that have now been at least partially investigated, attention is being paid to the Basidiomycetes to w'hich a large number of the fungi belong. The fruits or sporophores of this type of fungus have in many instances been found to contain antibacterial substances which can be extracted by grinding up the sporophore with sand and physiological saline. Some of these fungi have been grown in artificial culture and the active principles have been isolated in a crystalline form, but so far they have all proved very toxic. There are, of course, many points of difficulty arising in the cultivation, not only of the Basidiomycetes bu't also of the Penicillia and Aspergilli, for example, the media on which they grow are of the greatest importance. Experiments have been conducted in growing a single species of fungus on six different media; on only two of 'them was an antibiotic produced, on three there was nothing, and on one a growth-promoting substance seemed to have been elaborated. This will give you perhaps sonie idea of the elaborate nature of even preliminary investigations into the production of antibiotics.
At the present time most interest is focussed around the group of organisms known as Actinomycetes. Waksman and his collaborators40 have been investigating this great group of organisms for many years. They first succeeded in isolating the very toxic substance known as actinomycin. Later they found a more interesting agen't known as streptothricin which had chemotherapeutic properties against certain Gram-negative organisms, but it proved too toxic for use in man; finally in 1944 they prepared "streptomycin," which bids fair to become a very important chemotherapeutic agent, since its *toxicity is low and its efficiency in animal infections has been clearly established. At present its use in man is 'being thoroughly explored with results which appear in many instances to carry great promise. Streptomycin is active against Gram-negative organisms which are unaffected by penicillin; and what is possibly much more important, the tubercle bacillus is affected by it both in vitro and in vivo. We are certainly going to hear a great deal more of this substance.
From the Actinomycetes, too, comes "proactinomycin," an agent that came from an accidental contaminant isolated in the laboratory and upon which we have been working in Oxford. Like streptomycin it is a base, but is mainly active against Gram-positive organ-isms. It just comes into the realm of chemotherapeutic agents, for it has been shown possible to prot-ect a proportion of mice infected with streptococci by doses of proactinomycin given by mouth. It is, however, quite unlikely to be used in medicine as its toxicity appears to be too great, and the chemotherapeutic effects not sufficiently marked. Thus, it can be seen that this group of organisms has already produced substances of the greatest interest. Whether others will be found remains to be seen.
Bacteria are also being actively investigated as a source of antibacterial agents. We have seen how the spore-formers have already produced tyrothrycin. Recently another substance which has been called "bacitracin" has been isolated from a strain of B. subtilis. In animal experiments this substance has been shown to have clear-cut chemotherapeutic properties. It is active against the same range of organisms as is penicillin, but little has yet been published concerning its properties.
Another substance which is probably different from bacitracin has also been isolated from B. subtilis and designated "subtilin."
This, apparently, has chemotherapeutic properties too. I, myself, believe that the group of spore-forming organisms probably produces a large number of different antibiotics, but only further investigation can clarify this field. It is possible that some of the products will be of value in medicine. Although much attention has been devoted to the spore-formers, it is well to remember that other bacteria also produce antibacterial substances. And I should just like to say a few words about that produced by Bact. coli. Gratia in 192519 described the existence of one 'strain of Bact. coli which was capable of inhibiting the growth of another strain of the same organism. He gave a description of some of its properties but the substance was not isolated. I have a special interest in substances produced by Bact. coli, for in 1929 I first personally encountered the phenomenon of antibiosis in that organism (isolated from cat feces) which we found to produce a substance that inhibited Micrococcus lysodeikticus. Recently Heatley and I have investigated the properties of the substance produced by a similar organism recently isolated from cat feces. When streaks of this organism have been grown on agar containing glucose and cross streaks of various organisms have been put on the same plate, we have found that all the organisms are inhibited in the neighborhood of the streak of Bact. coli. When a few drops of blood are added to the medium, only one organism, which is a strain of Bact. coli, is inhibited. The first inhibition is due to the production of hydrogen peroxide, while the inhibition in the second case is due to some other substance. This inhibition can be produced in fluid culture only when large volumes of air are continuously blown through the medium. It has proved very difficult to extract because it is not soluble in any of the usual organic solvents, but it has been possible to produce a highly purified and active preparation -of a highly specific nature. When the liquid is put on a plate of Bact. coli, resistant colonies are observed. These colonies by all the ordinary bacteriological tests do not differ from those which have been prevented from growing. It is not active against all strains of Bact. cols, but it does inhibit the growth of Shiga and some dysentery organisms and so far is not effective against 'other bacteria tested. It is thus highly specific against certain Gram-negative organisms but does not affect Gram-positive bacteria. It has very little toxicity, as much as 18 mg. being injected into a mouse without causing noticeable symptoms. It is very active under certain conditions for it will inhibit the growth of Bact. coli at a dilution of 1 in 60,000,000, but this effect is greatly dependent upon the size of the inoculum studied. It has no chance whatever of being a chemotherapeutic agent, h.owever, as it 's rapidly destroyed by trypsin, pepsin, and by slices of such tissues as kidney and liver; after injections of large amounts none, or practically none, appears in the urine. This perhaps will give you some glimpse of the fact that it is necessary to perform really comprehensive tests, many of them on animals, before an antibacterial agent, even though it appears to be non-toxic, can be ascertained to be of use in medicine. This one clearly stands no chance of it. There is no doubt that there are many other interesting substances to be extracted from bacteria and studied.
Another source which has been particularly investigated in this University is that of the lichens by Burkholder et al. 4 They have found that many lichens produce antibacterial substances. To date none of them, as far as I know, has been shown to have chemotherapeutic properties, and for this reason it appears at the moment unlikely that they will be of value in medicine, yet there are, no doubt, many antibacterial substances produced by this form of life.
Another great source of antibacterials are *the flowering plants. These have considerable historical interest because the herbalists from antiquity have used extracts of various parts of plants for application to infected wounds and other diseased parts of the body. Many thousands of plants have now been tested by grinding up their flowers, leaves, seeds, etc., with sand and water, and these extracts have been shown to contain powerful antibacterial substances. Favorable results were obtained with extracts of garlic, a species of spirea, and buttercups, but one plant, known as "self-heal" and highly recommended by medieval herbalists, proved to have no antibacterial effect. One of the most interesting substances which we have examined is that coming from the common wallflower. Compresses made from the leaves of this plant have been recommended from Roman times so that it is interesting to find that extracts of the leaves, flowers, and seeds all contain a powerful antibacterial substance which, on extraction, has been shown to be cheiroline. This is a crystalline mustard oil containing a sulphone group. It is quite a powerful antiseptic, but of no value chemotherapeutically because intravenous injections cause epileptiform fits. Nevertheless, it is of considerable interest to know that the old herbalists had succeeded in finding a strong antiseptic in many ways superior to carbolic acid so long used by surgeons.
This subject has now become so vast and the amount of information at our disposal so great that I have in this lecture done little more than indicate to you its scope. I hope that you now realize that there has been a long history to which hundreds of workers have contributed, that we know of the existence of many hundreds of substances, a few of which may be of considerable use in medicine. Even the possibility that some of these substances may be of use in disease conditions other than infections must be explored. It is a vast work which holds much interest to those engaged in it. 
